Advertisement

Topics

Quanterix Corporation Releases Operating Results for Fourth Quarter and Fiscal Year 2017

16:05 EDT 14 Mar 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Revenue at high end of range previously provided Successful IPO completed in December 2017 Launch of SR-X in Q4, earlier than planned Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomark...

Other Sources for this Article

Quanterix, Inc.
Joseph Driscoll, CFO, 617-301-9495
jdriscoll@quanterix.com
or
PAN Communications
Lauren Kaufman, 617-502-4300
quanterix@pancomm.com

NEXT ARTICLE

More From BioPortfolio on "Quanterix Corporation Releases Operating Results for Fourth Quarter and Fiscal Year 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...